Lipid-lowering therapies underused for primary CVD prevention - Healio

In a cohort of more than 400,000 patients at high risk for CVD requiring primary prevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies, researchers reported. For an abstract present…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio In a cohort of more than 400,000 patient… [+2314 chars]

full article...